Schedule 13G ownership disclosure

AEON Biopharma, Inc.

Class A Common Stock, $0.0001 par value per share · CUSIP: 00791X100

Event date: 2025-03-31

Filing-level shares
0
Percent of class
0%
  • Polar Asset Management Partners Inc.

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001326389-25-000190
Form type
SCHEDULE 13G/A
Filer
AEON Biopharma, Inc.
CIK
CIK 1837607
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub